Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Warfarin | |
Synonyms |
|
|
Definitions |
A synthetic anticoagulant. Warfarin inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors, which include Factors II, VII, IX and X, and the anticoagulant proteins C and S. This inhibition results in a sequential depression of Factors VII, IX, X and II activities. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K dependent clotting factors. The vitamin promotes the biosynthesis of gamma-carboxyglutamic acid residues in these proteins which are essential for biological activity. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C945 |
|
Accepted_Therapeutic_Use_For |
Pulmonary embolism and thromboembolic disorders, treatment and prophylaxis; Venous thrombosis, prophylaxis and treatment
|
|
ALT_DEFINITION |
A drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).
|
|
CAS_Registry |
81-81-2
|
|
CHEBI_ID |
CHEBI:10033
|
|
Chemical_Formula |
C19H16O4
|
|
code |
C945
|
|
Contributing_Source |
CTRP FDA
|
|
definition |
A synthetic anticoagulant. Warfarin inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors, which include Factors II, VII, IX and X, and the anticoagulant proteins C and S. This inhibition results in a sequential depression of Factors VII, IX, X and II activities. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K dependent clotting factors. The vitamin promotes the biosynthesis of gamma-carboxyglutamic acid residues in these proteins which are essential for biological activity.
|
|
Display_Name |
Warfarin
|
|
FDA_UNII_Code |
5Q7ZVV76EI
|
|
Has_Salt_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Warfarin
|
|
Legacy Concept Name |
Warfarin
|
|
NCI_Drug_Dictionary_ID |
39740
|
|
NSC Number |
59813
|
|
PDQ_Closed_Trial_Search_ID |
39740
|
|
PDQ_Open_Trial_Search_ID |
39740
|
|
Preferred_Name |
Warfarin
|
|
prefixIRI |
NCIT:C945
|
|
prefLabel |
Warfarin
|
|
Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
UMLS_CUI |
C0043031
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping